Published in Genes Immun on December 04, 2014
Dendritic cells and the control of immunity. Nature (1998) 56.54
Interleukin-10-deficient mice develop chronic enterocolitis. Cell (1993) 22.57
IL-22 increases the innate immunity of tissues. Immunity (2004) 8.30
Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature (1997) 5.80
Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science (1998) 4.97
IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol (2006) 4.88
Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med (1996) 4.15
Biology of interleukin-10. Cytokine Growth Factor Rev (2010) 3.41
Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity (2003) 3.28
Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. J Clin Invest (1999) 3.00
Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med (1998) 2.30
The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages. Eur J Immunol (1993) 2.08
Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function. Immunity (2014) 2.06
Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J (1997) 2.03
IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. J Immunol (1995) 1.97
IL-10-dependent partial refractoriness to Toll-like receptor stimulation modulates gut mucosal dendritic cell function. Eur J Immunol (2008) 1.97
Therapeutic opportunities of the IL-22-IL-22R1 system. Nat Rev Drug Discov (2014) 1.94
A receptor for interleukin 10 is related to interferon receptors. Proc Natl Acad Sci U S A (1993) 1.91
Expression cloning and characterization of a human IL-10 receptor. J Immunol (1994) 1.89
Dendritic cells as the terminal stage of monocyte differentiation. J Immunol (1998) 1.87
Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines. Genes Immun (2009) 1.81
Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action. J Biol Chem (1999) 1.77
IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not. J Mol Med (Berl) (2009) 1.76
IL-10 family of cytokines. Cytokine Growth Factor Rev (2010) 1.70
Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site. Immunity (2001) 1.64
Clinical use of dendritic cells for cancer therapy. Lancet Oncol (2014) 1.63
Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood (2000) 1.58
Is there an interaction between interleukin-10 and interleukin-22? Genes Immun (2005) 1.54
IL-28A, IL-28B, and IL-29: promising cytokines with type I interferon-like properties. Cytokine Growth Factor Rev (2010) 1.45
Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs. Exp Dermatol (2006) 1.41
The functional characterization of interleukin-10 receptor expression on human natural killer cells. Blood (1995) 1.26
A whole genome methylation analysis of systemic lupus erythematosus: hypomethylation of the IL10 and IL1R2 promoters is associated with disease activity. Genes Immun (2011) 1.11
IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasis. Sci Transl Med (2013) 1.09
Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-β. Genes Immun (2014) 1.05
Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa. J Immunol (2010) 1.04
Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells. Blood (1997) 1.04
Interleukin-26: an IL-10-related cytokine produced by Th17 cells. Cytokine Growth Factor Rev (2010) 1.03
Exome sequencing identifies novel compound heterozygous mutations of IL-10 receptor 1 in neonatal-onset Crohn's disease. Genes Immun (2012) 1.01
Wnt5a induces a tolerogenic phenotype of macrophages in sepsis and breast cancer patients. J Immunol (2012) 0.99
Expression profiling of IL-10-regulated genes in human monocytes and peripheral blood mononuclear cells from psoriatic patients during IL-10 therapy. Eur J Immunol (2004) 0.98
Stat3 promotes IL-10 expression in lupus T cells through trans-activation and chromatin remodeling. Proc Natl Acad Sci U S A (2014) 0.96
TGF-β-associated miR-27a inhibits dendritic cell-mediated differentiation of Th1 and Th17 cells by TAB3, p38 MAPK, MAP2K4 and MAP2K7. Genes Immun (2012) 0.96
Interleukin-10 enhances the CD14-dependent phagocytosis of bacteria and apoptotic cells by human monocytes. Hum Immunol (2007) 0.96
IL-19 is a component of the pathogenetic IL-23/IL-17 cascade in psoriasis. J Invest Dermatol (2014) 0.94
Reduced monocyte CD86 expression in postinflammatory immunodeficiency. Crit Care Med (2007) 0.90
IL-10 restrains IL-17 to limit lung pathology characteristics following pulmonary infection with Francisella tularensis live vaccine strain. Am J Pathol (2013) 0.87
An intracytoplasmic IL-10 receptor variant permits rapid reduction in STAT3 activation. Genes Immun (2011) 0.84
Evidence for conformationally different states of interleukin-10: binding of a neutralizing antibody enhances accessibility of a hidden epitope. J Mol Recognit (2000) 0.81
Inhibition of interleukin-10 signaling in lung dendritic cells by toll-like receptor 4 ligands. Exp Lung Res (2009) 0.80
Efficiency of dendritic cell vaccination against B16 melanoma depends on the immunization route. PLoS One (2014) 0.79
Statins for heart failure: at the crossroads between cholesterol reduction and pleiotropism? Heart (2005) 1.17
The obesity paradox in heart failure: accepting reality and making rational decisions. Clin Pharmacol Ther (2011) 0.92
Matrix metalloproteinase 9/neutrophil gelatinase associated lipocalin/tissue inhibitor of metalloproteinasess type 1 complexes are localized within cardiomyocytes and serve as a reservoir of active metalloproteinase in porcine female myocardium. J Physiol Pharmacol (2014) 0.76
Erratum to: Recent developments in the treatment of cachexia: highlights from the 6th Cachexia Conference. J Cachexia Sarcopenia Muscle (2012) 0.75
[Immunactivation in chronic heart failure. Inflammatory mediators]. Z Kardiol (2004) 0.75
Interleukin-10 receptor-1 expression in monocyte-derived antigen-presenting cell populations: dendritic cells partially escape from IL-10's inhibitory mechanisms. Genes Immun (2015) 0.75